In The News
Xoft® is the only FDA cleared electronic brachytherapy (eBx®) system that has been used to treat 10,000 plus non-melanoma skin
cancer patients & is supported by positive
4-year clinical data.
iCAD is committed to providing advanced cancer detection and treatment options for unparalleled care.
Learn more about CAD technology and Xoft® eBx® for your cancer treatment.
Surgery is not the only option.
Learn more about eBx® for non-melanoma skin cancer treatment.
IORT & APBI
“I came in with cancer, went to sleep, and when I woke up, I was completely done with my breast cancer treatment.”
–Marianne, IORT Patient Learn more.
Learn more about GYN eBx® for your gynecological cancer treatment.
Computer-Aided Detection (CAD)
iCAD technology helps physicians and patients in the fight against the most prevalent cancers: breast, colorectal, and prostate. Learn more about CAD.
iCAD, Inc. Announces Information Related To Reimbursement Levels.
iCAD Launches Digital Customer Training Platform to Support Professional Education in Use of Xoft System for Treatment of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer and Gynecological Cancers.
iCAD Reports First Quarter 2015 Financial Results.